Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study

Viral Response ◽

Early Viral Response ◽

Baseline Factors ◽

A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study

Hepatology Research ◽

10.1111/hepr.12323 ◽

2014 ◽

Vol 44 (14) ◽

pp. E386-E396 ◽

Cited By ~ 2

Author(s):

Noritomo Shimada ◽

Akihito Tsubota ◽

Masanori Atsukawa ◽

Hiroshi Abe ◽

Tatsuya Ide ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Multicenter Study ◽

Response Rate ◽

Sustained Virological Response Rate ◽

Triple Combination ◽

Virological Response Rate ◽

Peginterferon And Ribavirin

PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate

Intervirology ◽

10.1159/000252786 ◽

2010 ◽

Vol 53 (1) ◽

pp. 60-65 ◽

Cited By ~ 4

Author(s):

Norihisa Yada ◽

Masatoshi Kudo ◽

Hobyung Chung ◽

Sosuke Hayaishi ◽

Masahiro Takita ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Serum Ferritin Level ◽

Response Rate ◽

Ferritin Level ◽

Sustained Viral Response ◽

Sustained Viral Response Rate ◽

Viral Response ◽

Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir:Daclatasvir combination therapy

Hepatology Research ◽

10.1111/hepr.12667 ◽

2016 ◽

Vol 46 (11) ◽

pp. 1162-1167 ◽

Cited By ~ 2

Author(s):

Itaru Ozeki ◽

Tomoaki Nakajima ◽

Masakatsu Yamaguchi ◽

Mutsuumi Kimura ◽

Tomohiro Arakawa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Triple Combination ◽

Triple Combination Therapy

Efficacy and safety of interferon alfa-2b and ribavirin combination therapy in chronic hepatitis C patients: a Czech multicenter study

Journal of Hepatology ◽

10.1016/s0168-8278(02)80849-2 ◽

2002 ◽

Vol 36 ◽

pp. 237

Author(s):

Petr Husa ◽

Vladislav Krtek ◽

Jiri Svejda ◽

Jaroslav Stransky ◽

Blanka Cieslarova ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Multicenter Study ◽

Interferon Alfa ◽

Efficacy And Safety ◽

Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study

Journal of Medical Virology ◽

10.1002/jmv.23428 ◽

2012 ◽

Vol 85 (1) ◽

pp. 65-70 ◽

Cited By ~ 4

Author(s):

Hidenori Toyoda ◽

Takashi Kumada ◽

Noritomo Shimada ◽

Koichi Takaguchi ◽

Tatsuya Ide ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Multicenter Study ◽

Virologic Response ◽

Genotype 1 ◽

Virus Genotype ◽

Viral Response ◽

Early Viral Response ◽

Baseline Factors ◽

Peginterferon And Ribavirin

Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response

Hepatology Research ◽

10.1111/j.1872-034x.2009.00523.x ◽

2009 ◽

Vol 39 (8) ◽

pp. 753-759 ◽

Cited By ~ 11

Author(s):

Hiroki Ikeda ◽

Michihiro Suzuki ◽

Chiaki Okuse ◽

Norie Yamada ◽

Masaru Okamoto ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Short Term ◽

Viral Response ◽

Genotype 1B ◽

Early Viral Response ◽

APRI as a predictor of early viral response in chronic hepatitis C patients

World Journal of Gastroenterology ◽

10.3748/wjg.15.4923 ◽

2009 ◽

Vol 15 (39) ◽

pp. 4923 ◽

Cited By ~ 5

Author(s):

José A Mata-Marín ◽

José L Fuentes-Allen ◽

Jesús Gaytán-Martínez ◽

Bulmaro Manjarrez-Téllez ◽

Alberto Chaparro-Sánchez ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Viral Response ◽

Early Viral Response ◽

α-Fetoprotein is a surrogate marker for predicting treatment failure in telaprevir-based triple combination therapy for genotype 1b chronic hepatitis C Japanese patients with theIL28Bminor genotype

Journal of Medical Virology ◽

10.1002/jmv.23824 ◽

2013 ◽

Vol 86 (3) ◽

pp. 461-472 ◽

Cited By ~ 5

Author(s):

Noritomo Shimada ◽

Akihito Tsubota ◽

Masanori Atsukawa ◽

Hiroshi Abe ◽

Makiko Ika ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Treatment Failure ◽

Chronic Hepatitis C ◽

Surrogate Marker ◽

Japanese Patients ◽

Triple Combination ◽

Genotype 1B

P137: Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients

Journal of Viral Hepatitis ◽

10.1111/jvh.127_12425 ◽

2015 ◽

Vol 22 ◽

pp. 88-89

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Hemodialysis Patients ◽

Triple Combination ◽

Triple Combination Therapy

Heading the triple combination therapy!? Treatment results in retreated patients with hepatitis C (G1)

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1278525 ◽

2011 ◽

Vol 49 (05) ◽

Author(s):

M Varga ◽

K Csefkó ◽

I Nagy ◽

A Pálvölgyi ◽

T Martyin ◽

...

Keyword(s):

Hepatitis C ◽

Combination Therapy ◽

Triple Combination ◽

Treatment Results ◽

Therapy Treatment